3 ms·
HCQ has been around for 70 years. Remdesivir's issue is that everyone gets to be the guinea pig. Sometimes it's better to go with the devil you know.
by ytNumbers 6y ago
HCQ has been around for 70 years. Remdesivir's issue is that everyone gets to be the guinea pig. Sometimes it's better to go with the devil you know.
- ceejayoz 6y ago> HCQ has been around for 70 years. Not in an antiviral context, and certainly not for SARS-CoV-2.
- dpoochieni 6y agoSo? The point here is the safety of it, plus there's research going back to 2006 about its effectiveness for other Coronaviruses. I mean do whatever you want to do, but there's a reason most people in government are taking it. In my country they privately take it, while publicly not endorsing it to prevent shortages
- DanBC 6y ago> The point here is the safety of it Yes, which is why all of the studies keep saying that it's too dangerous to use as treatment for covid-19.
- lbeltrame 6y agoToo dangerous (or even ineffective) to use it with patients with severe COVID-19. Whether it may be the same or not in a prophylaxis regime or for outpatient use (mild to moderate that does not require hospitalization) is yet unknown at this point (most papers that I've read are on hospitalized patients). It may be too toxic, it may not cause a noticeable effect, but currently it is a big question mark.
- DanBC 6y agoYou'd take the risk for people with severe Covid-19 because it might[1] save their life. You can't justify taking that risk in other people because they're probably not going to be killed by covid-19. Balancing harm from medication against not much harm from covid comes out against the meds. [1] Except now we know (and we always thought this) that it won't save their life; it'll increase their risk of death.
- marvin 6y agoSame stories I've heard. Many doctors prescribing it for prophylactic treatment to friends and family immediately after diagnosis. Some government officials (in France, notably! While at the same time shutting down public use) taking it immediately after diagnosis. As has been mentioned elsewhere, we'll have to answer soon, but power speaks with a forked tongue in this case. Too many anecdotal observations to be comfortable in the very loud politicization of the science. The Lancet study and others cannot be accepted a conclusion to the safety & efficacy of early/prophylactic use. Let's wait for and encourage some proper, specific studies.